Skip to main content

Table 2 Differences in process outcomes by decision aid received

From: Head to head randomized trial of two decision aids for prostate cancer

 

N

Complex DA

Simple DA

Abs. diff/(CI)

t/(p value)

Knowledge (proportion correct,12 item scale)

279

0.48

0.53

0.05 (− 0.01, 0.11)

1.57 (0.116)

Interest in shared decision making

 Biopsy interview

1012

3.30

3.34

0.04 (− 0.05, 0.14)

0.88 (0.380)

 Pre-clinic interview

281

3.33

3.50

0.16* (0.02, 0.31)

2.20 (0.027)

 Post-clinic interview

241

3.50

3.60

0.10 (− 0.06, 0.26)

1.19 (0.235)

Anxiety

 Biopsy interview

1005

1.02

1.07

0.05 (− 0.04, 0.14)

1.06 (0.290)

 Pre-clinic interview

280

1.08

1.12

0.03 (− 0.13, 0.20)

0.39 (0.694)

 Post-clinic interview

240

2.08

2.15

0.07 (− 0.12, 0.25)

0.72 (0.474)

How helpful was the DA

 Influencing treatment

272

3.02

3.32

0.31 (− 0.02, 0.63)

1.86 (0.063)

 Understanding prostate cancer

272

3.76

4.13

0.38** (0.11, 0.64)

2.78 (0.005)

 Understanding treatment options

272

3.49

3.89

0.40** (0.14, 0.67)

2.96 (0.003)

 How much they liked the DA

272

3.77

4.09

0.32* (0.04, 0.59)

2.28 (0.022)

Patient–physician communication:

 COMRADE

 

2414.25

4.28

0.03 (− 0.13, 0.18)

0.31 (0.757)

 PICS: MD facilitation

 

2391.69

1.75

0.06 (− 0.02, 0.13)

1.47 (0.141)

  1. Results analyzed accounting for stratified randomization by site, race and literacy as random effects
  2. *p < 0.05; **p < 0.01; ***p < .001